Delta Point Continues to Expand Management Capabilities with Addition of
Pharmaceutical Industry Leader Cathy Geddes
MALVERN, Pa., April 3, 2013
MALVERN, Pa., April 3, 2013 /PRNewswire/ --Cathy Geddes, former commercial
leader at Pfizer, Wyeth and Roche, has recently joined Delta Point, Inc. as
Senior Vice President with responsibility for leading the operations of the
business and developing innovative new marketing offerings. "Over the last few
months Delta Point has brought in key talent who will enhance the company. In
addition to Michael Hickey who recently joined as Senior Vice President of
Global Leadership Development, Cathy has joined DPI to lead our efforts in
improving internal organization processes and infrastructure which will allow
us to continue to grow and fulfill our vision of being the premier specialty
consulting firm in the life science space. As we've experienced significant
growth over the last few years, it's the appropriate time to create a role
committed to leading Operations," explained Jerry Acuff, founder and CEO of
Delta Point. "Cathy's background and experience is also ideal for evolving our
Marketing products to assist clients in optimizing brand performance," said
Geddes has a deep understanding of the pharmaceutical business having worked
in the industry for over 20 years as a leader in marketing, sales, and account
management in start-up, mid-size and large pharmaceutical organizations. She
began her healthcare career in Marketing at start-up biotechnology company
where she led the launch of an oncology product. She then spent 12 years at
Roche Laboratories in various roles including Division Sales Manager, Regional
Account Manager, National Account Manager, Regional Sales Director and several
years leading the hepatology specialty sales force as National Sales Director.
While at Roche she earned numerous awards, successfully launched eight
products and gained experience promoting retail, hospital, and specialty
products across 14 therapeutic areas. Geddes joined Wyeth in 2007 when she was
recruited to lead the vaccine specialty sales team for several years as Vice
President of Sales. After the Pfizer acquisition of Wyeth, she was asked to
lead the Marketing team in the launch of Prevnar 13, a "buy & bill" specialty
care pneumococcal vaccine, which under her leadership became the #1 product in
first year sales in pharmaceutical history with over $2B in US revenue. She
has a B.A. from Temple University and a M.B.A. from St. Joseph's University.
About Delta Point, Inc.
Headquartered in Scottsdale, AZ with a regional office in Malvern, PA, Delta
Point, Inc. specializes in the life sciences industry (pharmaceutical,
biotech, and device companies) by partnering with clients to maximize brand
sales performance. Their focus is on improving outcomes by analyzing the needs
of their customers before developing customized recommendations that align
cross-functional departments: Sales, Marketing, Sales Training and Commercial
Operations. Delta Point specializes in making those changes that help
corporations deal with the challenges they face whether it is launching a new
product or an underperforming brand by working with their clients as a partner
in attaining business success. They have gained recognition for developing
strategic sales and marketing plans, improving sales messaging, and for the
effectiveness of their training programs, including a copyrighted process of
building, sustaining and growing substantive business relationships.
Jerry Acuff, CEO
Delta Point, Inc.
This press release was issued through eReleases® Press Release Distribution.
For more information, visit http://www.ereleases.com.
SOURCE Delta Point, Inc.
Press spacebar to pause and continue. Press esc to stop.